Birmingham Vasculitis Activity Scores (BVAS) were used to identify disease manifestations. Key efficacy outcomes included remission at week 26, sustained remission at week 52, relapse rates, the ...

Identification of risk factors for relapse of ANCA-associated small-vessel vasculitis would allow therapy ... suffered relapse. Lung and upper respiratory tract vascular sclerosis, and ...

Researchers found that use of immunosuppressive medication was a strong protective factor, associated with a 60% reduction in ...

Bosch and colleagues searched MEDLINE for studies published in English between 1966 and 2007 that evaluated the available treatments for antineutrophil cytoplasmic antibody (ANCA)-associated ...